Prognostic value of the 21-gene recurrence score in ER-positive, HER2-negative, node-positive breast cancer was similar in node-negative diseases: a single-center study of 800 patients / 医学前沿
Frontiers of Medicine
; (4): 621-628, 2021.
Article
en En
| WPRIM
| ID: wpr-888733
Biblioteca responsable:
WPRO
ABSTRACT
Multi-gene assays have emerged as crucial tools for risk stratification in early-stage breast cancer. This study aimed to evaluate the prognostic significance of the 21-gene recurrence score (RS) in Chinese patients with pN0-1, estrogen receptor-positive (ER
Palabras clave
Texto completo:
1
Índice:
WPRIM
Asunto principal:
Pronóstico
/
Neoplasias de la Mama
/
Receptores de Estrógenos
/
Biomarcadores de Tumor
/
Receptor ErbB-2
/
Recurrencia Local de Neoplasia
/
Estadificación de Neoplasias
Tipo de estudio:
Prognostic_studies
Límite:
Female
/
Humans
Idioma:
En
Revista:
Frontiers of Medicine
Año:
2021
Tipo del documento:
Article